Cargando…
Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo
Hepatocellular carcinoma (HCC) is a vital global health problem. The characteristics are high morbidity, high mortality, difficulty in early diagnosis and insensitivity to chemotherapy. The main therapeutic schemes for treating HCC mainly include Tyrosine kinase inhibitors represented by sorafenib a...
Autores principales: | Xie, Xudong, Li, Li, Tao, Shuai, Chen, Mingsheng, Fei, Ling, Yang, Qunling, Huang, Chenlu, Chen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966472/ https://www.ncbi.nlm.nih.gov/pubmed/36834630 http://dx.doi.org/10.3390/ijms24043217 |
Ejemplares similares
-
The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016) -
Proto-oncogene FAM83A contributes to casein kinase 1–mediated mitochondrial maintenance and white adipocyte differentiation
por: Huang, Kuilong, et al.
Publicado: (2022) -
Role of proto-oncogene activation in carcinogenesis.
por: Anderson, M W, et al.
Publicado: (1992) -
The Biology of the Ets1 Proto-Oncogene
por: Dittmer, Jürgen
Publicado: (2003) -
Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2021)